BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23903502)

  • 1. Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion.
    Tatsuta T; Yoshimura T; Hasui K; Takasugi K; Sawaya M; Hanabata N; Shimoyama T; Kijima H; Fukuda S
    Intern Med; 2013; 52(15):1697-701. PubMed ID: 23903502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Tumors of the Stomach.
    Corey B; Chen H
    Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 3mm Gastric Neuroendocrine Tumor That Metastasized to a Lymph Node].
    Fukui Y; Kato Y; Okazaki Y; Kushitani Y; Kametani N; Tokumoto M; Yoshii M; Ako E; Yamada N; Nishimura S; Taenaka N
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1839-1841. PubMed ID: 30692371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Types of Gastric Cancer Caused by the Same Underlying Condition.
    Rustgi N; Shroff SG; Katona BW
    Gastroenterology; 2018 Apr; 154(5):1246-1248. PubMed ID: 29410354
    [No Abstract]   [Full Text] [Related]  

  • 6. An atypical type I gastric neuroendocrine tumor.
    Gheorghe AV; Rimbas M; Ginghina O; Spanu A; Voiosu TA
    Rom J Intern Med; 2017 Dec; 55(4):253-256. PubMed ID: 28710883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Early Gastric Cancer/Neuroendocrine Tumor Associated with Autoimmune Gastritis Completely Resected with Endoscopic Submucosal Dissection.
    Kubo K; Kimura N; Matsuda S; Mabe K; Kato M
    Intern Med; 2019 Sep; 58(18):2633-2637. PubMed ID: 31178500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of a tumor comprising gastric cancer and duodenal neuroendocrine tumor.
    Kaneko H; Miyake A; Ishii Y; Sue S; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S
    World J Gastroenterol; 2016 Sep; 22(36):8242-6. PubMed ID: 27688667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
    Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
    Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
    Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
    Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for lymph node metastasis in early gastric cancer with lymphatic invasion after endoscopic resection.
    Park JW; Ahn S; Lee H; Min BH; Lee JH; Rhee PL; Kim KM; Kim JJ
    Surg Endosc; 2017 Nov; 31(11):4419-4424. PubMed ID: 28378075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases.
    Sunagawa H; Kinoshita T; Kaito A; Shibasaki H; Kaneko K; Ochiai A; Ohtsu A; Nishida T
    Surg Today; 2017 Feb; 47(2):202-209. PubMed ID: 27194020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A minute, solitary carcinoid of the stomach with a lymph node metastasis--a case report].
    Naitoh H; Kumashiro R; Teshima K; Oku K; Inutsuka S; Egashira K; Murayama H
    Gan No Rinsho; 1988 Jun; 34(7):908-13. PubMed ID: 3398263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
    Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
    Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metachronous solitary splenic metastasis arising from early gastric cancer: a case report and literature review.
    Namikawa T; Kawanishi Y; Fujisawa K; Munekage E; Munekage M; Sugase T; Maeda H; Kitagawa H; Kumon T; Hiroi M; Kobayashi M; Hanazaki K
    BMC Surg; 2017 Aug; 17(1):96. PubMed ID: 28851346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of lymph node metastasis in mucosal gastric cancer with extra indication for endoscopic mucosal resection.
    Yoshikawa K; Hiki N; Fukunaga T; Tokunaga M; Yamamoto Y; Miki A; Ogawa K; Higashijima J; Ohyama S; Seto Y; Shimada M; Yamaguchi T
    J Am Coll Surg; 2009 Jun; 208(6):1045-50. PubMed ID: 19476890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.